Prevention of hypokalaemia and hypomagnesaemia following peripheral stem cell collection – a prospective cohort study

Abstract

Background and objectives Citrate‐based anticoagulation reduces plasma potassium and free magnesium in patients undergoing peripheral stem cell collections. Whether the effects may be mitigated by pre‐procedure oral electrolyte supplements has not been previously assessed. Materials and methods Results from a historic cohort (2010–2013) guided a systematic prospective intervention in subjects deemed at risk for clinically meaningful hypokalaemia and hypomagnesaemia. From 2015 to 2019, 136 patients were enrolled in the study. Pre‐ and post‐apheresis electrolyte levels were measured, and oral potassium and magnesium supplements were systematically administered based on the pre‐ electrolyte levels. Results We saw a 37% absolute reduction in severe hypokalaemia and 39% absolute reduction in hypomagnesaemia in the prospective intervention cohort when compared to the historic cohort. Multivariate analyses indicated that part of the effect was due to the electrolyte intervention, while part of the effect likely stemmed from other procedure‐related changes implemented during the study period. Conclusion Oral potassium and magnesium prophylaxis appear to reduce hypokalaemia and hypomagnesaemia following peripheral stem cell collection. Whether the effect size is sufficient to motivate the intervention warrants further investigation, preferably in a prospective randomized trial setting.